On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, ...

As part of the three-year agreement, Gilead has agreed to take a series of actions that align with the government’s new drug ...

Novartis has announced an agreement with the US government to lower the prices of its medicines in the US and support ...

Merck (known as MSD outside the US) has announced an agreement with the US government to provide key products to patients at ...

Novo Nordisk’s Wegovy (semaglutide) pill has been approved by the US FDA as an oral weight loss medication. In addition to ...

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story ...

Radical Departures specialises in interactive medical and healthcare communications. Our team combines creativity with extensive medical and scientific experience. We have been designing and ...

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical and biotech clients to ...

Globe Life Sciences provides commercial evaluation and information services within healthcare-related sectors. The company specialises in the evaluation of products, diseases and companies to support ...

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more to find out.

Pfizer’s Abrysvo has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the first respiratory syncytial virus (RSV) vaccine to protect both infants through maternal ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted UCB’s Bimzelx (bimekizumab) two new approvals, with the inflammatory disease drug now authorised to treat certain adults with ...